Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer

被引:5
作者
Martin II, Robert C. G. [1 ,2 ]
Schoen, Eric C. [1 ]
Philips, Prejesh [1 ]
Egger, Michael E. [1 ]
McMasters, Kelly M. [1 ]
Scoggins, Charles R. [1 ]
机构
[1] Univ Louisville, Sch Med, Hiram C Polk Jr MD Dept Surg, Div Surg Oncol, Louisville, KY 40202 USA
[2] Univ Louisville, Div Surg Oncol, 315 East Broadway, M-10,Room 311, Louisville, KY 40202 USA
关键词
DUCTAL ADENOCARCINOMA; NEOADJUVANT THERAPY; PANCREATICODUODENECTOMY; BORDERLINE; SURVIVAL; DISSECTION; MANAGEMENT; PATTERNS; ABLATION;
D O I
10.1016/j.surg.2022.07.033
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The purpose of this study was to evaluate the rates of local recurrence and margin positivity in patients with borderline resectable pancreatic cancer after pancreatectomy with or without irre-versible electroporation with margin accentuation.Methods: Prospective data for preoperative stages IIB (borderline resectable) and III were evaluated, with 75 patients undergoing pancreatectomy with irreversible electroporation with margin accentuation compared to 71 patients who underwent pancreatectomy alone from March 2010 to November 2020. Results: Both irreversible electroporation with margin accentuation and pancreatectomy-alone groups were similar for body mass index, Charleston comorbidity index, and sex. The irreversible electroporation with margin accentuation group had significantly greater preoperative stage III (irreversible electroporation 83% vs pancreatectomy alone 51%; P = .0001), with similar tumor location (head 64% vs 72%) and tumor size (median 2.9 vs 2.8). Neoadjuvant/induction chemotherapy and prior radiation therapy was similar in both groups (irreversible electroporation with margin accentuation 89% vs 72%). Surgical therapy included a greater percentage of pancreaticoduodenectomy in the pancreatectomy-alone group. Despite greater stage and greater percentage of margin positivity (irreversible electroporation with margin accentuation 27% vs 20%; P = not significant), rates of local recurrence were similar. The mean disease-free interval for local recurrence from time of diagnosis was similar (irreversible electroporation with margin accentuation 15.8 vs 16.5 pancreatectomy alone; P = not significant) and time of treatment (irreversible electroporation with margin accentuation 9.4 vs 10.5 months; P = not significant). Overall survival was improved with the irreversible electroporation with margin accentuation group, with a mean of 34.2 months versus 27.9 months in the pancreatectomy-alone group.Conclusion: Irreversible electroporation with margin accentuation is safe and effective in stages IIB and III pancreatic adenocarcinomas that are technically resectable. Despite higher margin positivity rates, the time to local recurrence and the effects of recurrence were the same in the pancreatectomy-alone group.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:581 / 589
页数:9
相关论文
共 45 条
  • [41] Resection margins and R1 rates in pancreatic cancer - are we there yet?
    Verbeke, C. S.
    [J]. HISTOPATHOLOGY, 2008, 52 (07) : 787 - 796
  • [42] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18) : 1691 - 1703
  • [43] Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data
    Weyhe, Dirk
    Obonyo, Dennis
    Uslar, Verena Nicole
    Stricker, Ingo
    Tannapfel, Andrea
    [J]. PLOS ONE, 2021, 16 (03):
  • [44] The Landmark Series: Locally Advanced Pancreatic Cancer and Ablative Therapy Options
    White, Rebekah R.
    Murphy, James D.
    Martin, Robert C. G.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4173 - 4180
  • [45] Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival
    Woeste, Matthew R.
    Wilson, Khaleel D.
    Kruse, Edward J.
    Weiss, Matthew J.
    Christein, John D.
    White, Rebekah R.
    Martin, Robert C. G.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11